血管内皮細胞成長因子受容体の阻害によるTh17炎症疾患治療方法およびこのための薬学的組成物

Title:

血管内皮細胞成長因子受容体の阻害によるTh17炎症疾患治療方法およびこのための薬学的組成物

Document Type and Number:

Japanese Patent JP5513620

Kind Code:

B2

Abstract:

The present invention relates to a method for treating or preventing Th17 inflammatory disease mediated with IL-6 or IL-17 by administration of medication which inhibits vascular endothelial growth factor receptors, and a pharmaceutical composition therefor.

More Like This:

JP4578105	CC-1065 Related substance improvement synthesis method
JP2691141	POLYPEPTIDES USEFUL AS EXCITATORY AMINO ACID NEURO TRANSMITTER ANTAGONIST AND/OR CALCIUM CHANNEL BLOCKER
WO/2002/024635	AMINOALCOHOL DERIVATIVES

Inventors:

Kim, Yun-Gun
Ko, Yong-Soon
Kim, Yu Seung

Application Number:

JP2012526617A

Publication Date:

June 04, 2014

Filing Date:

May 20, 2010

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Postec Academy-Industry Foundation

International Classes:

A61K31/404; A61K31/502; A61K38/00; A61K39/395; A61P29/00; A61P37/02; A61P37/08; A61P43/00

Domestic Patent References:

JP2007537245A
JP2004513964A

Foreign References:

WO2007009071A1
WO2008106451A1

Attorney, Agent or Firm:

Patent Business Corporation Unias International Patent Office

Previous Patent: JPS5513619

Next Patent: JPS5513621